56 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
3 May 21
Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results
8:54am
. The oral presentation included new weight loss data that showed patients with HET obesity who were classified as setmelanotide-responsive at three months … deficiency with POMC, PCSK1, or LEPR variants classified as benign or likely benign;
Other types of obesity not related to POMC, PCSK1 or LEPR deficiency
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
9 Nov 18
Management’s Discussion and Analysis of Financial Condition and Results of Operations
4:14pm
consist of investments with original maturities greater than 90 days, as of the date of purchase. The Company has classified its investments … /Obligation and 2015 Series A Investor Call Option
The Company classified its 2017 Series A Investor Instrument, 2015 Series A Investor Right/Obligation
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Apr 24
Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
5:25pm
or LEPR deficiency with POMC, PCSK1 or LEPR variants classified as benign or likely benign
Other types of obesity not related to POMC, PCSK1 or LEPR
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
3 May 22
Rhythm Pharmaceuticals Reports First Quarter 2022 Financial Results and Business Update
7:05am
due to suspected POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPR variants classified as benign or likely benign;
Other types of obesity
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
1 Mar 21
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
9:01am
due to suspected POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPR variants classified as benign or likely benign;
Other types of obesity
8-K
EX-99.1
m6poebtci
3 Aug 21
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
v22h nb4y99d67
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
a186qeqb2qu
7 May 24
Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update
7:10am
8-K
EX-99.1
o7opn9v kk
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
4a90dhrm hrlhnehq
2 Aug 22
Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
7:02am
8-K
EX-99.1
156u7n
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
8-K
EX-99.1
f7i2bm5hhdkdx 666
2 Nov 21
Rhythm Pharmaceuticals Reports Third Quarter 2021 Financial Results
7:05am